Meta-analysis of prognostic studies for a biomarker with a study-specific cutoff value

被引:5
作者
Sadashima, Eiji [1 ,2 ]
Hattori, Satoshi [3 ]
Takahashi, Kunihiko [4 ]
机构
[1] Kurume Univ, Grad Sch Med, 67 Asahi Machi, Kurume, Fukuoka 8300011, Japan
[2] Shin Koga Hosp, Med Corp Tenjinkai, 120 Tenjin Chyou, Kurume, Fukuoka 8308577, Japan
[3] Kurume Univ, Ctr Biostat, 67 Asahi Machi, Kurume, Fukuoka 8300011, Japan
[4] Nagoya Univ, Grad Sch Med, Dept Biostat, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan
关键词
biomarker; cutoff value; finite-mixture model; meta-analysis; prognostic study; POSITRON-EMISSION-TOMOGRAPHY; INDIVIDUAL PATIENT DATA; LUNG-CANCER; PUBLICATION BIAS; SURVIVAL; MARKER;
D O I
10.1002/jrsm.1201
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
In prognostic studies, a summary statistic such as a hazard ratio is often reported between low-expression and high-expression groups of a biomarker with a study-specific cutoff value. Recently, several meta-analyses of prognostic studies have been reported, but these studies simply combined hazard ratios provided by the individual studies, overlooking the fact that the cutoff values are study-specific. We propose a method to summarize hazard ratios with study-specific cutoff values by estimating the hazard ratio for a 1-unit change of the biomarker in the underlying individual-level model. To this end, we introduce a model for a relationship between a reported log-hazard ratio for a 1-unit expected difference in the mean biomarker value between the low-expression and high-expression groups, which approximates the individual-level model, and propose to make an inference of the model by using the method for trend estimation based on grouped exposure data. Our combined estimator provides a valid interpretation if the biomarker distribution is correctly specified. We applied our proposed method to a dataset that examined the association between the biomarker Ki-67 and disease-free survival in breast cancer patients. We conducted simulation studies to examine the performance of our method. Copyright (c) 2016 John Wiley & Sons, Ltd.
引用
收藏
页码:402 / 419
页数:18
相关论文
共 45 条
  • [1] Individual participant data meta-analysis of prognostic factor studies: state of the art?
    Abo-Zaid, Ghada
    Sauerbrei, Willi
    Riley, Richard D.
    [J]. BMC MEDICAL RESEARCH METHODOLOGY, 2012, 12
  • [2] Akaike H., 1992, 2 INT S INF THEOR, P610, DOI [10.1007/978-1-4612-1694-0, 10.1007/978-1-4612-0919-538, 10.1007/978-1-4612-0919-5_38, 10.1007/978-0-387-98135-2, DOI 10.1007/978-1-4612-0919-538]
  • [3] Systematic reviews in health care - Systematic reviews of evaluations of prognostic variables
    Altman, DG
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2001, 323 (7306): : 224 - 228
  • [4] Systematic review of multiple studies of prognosis: The feasibility of obtaining individual patient data
    Altman, Douglas G.
    Trivella, Marialena
    Pezzella, Francesco
    Harris, Adrian L.
    Pastorino, Ugo
    [J]. ADVANCES IN STATISTICAL METHODS FOR THE HEALTH SCIENCES: APPLICATIONS TO CANCER AND AIDS STUDIES, GENOME SEQUENCE ANALYSIS, AND SURVIVAL ANALYSIS, 2007, : 3 - +
  • [5] [Anonymous], 2008, EM ALGORITHM EXTENSI
  • [6] [Anonymous], 1993, Continuous Univariate Distributions, DOI DOI 10.1016/0167-9473(96)90015-8
  • [7] [Anonymous], 2010, BMJ-BRIT MED J, DOI DOI 10.1136/BMJ.C1842
  • [8] Prognostic significance of tumor cell proliferation analyzed in fine needle aspirates from primary breast cancer
    Billgren, AM
    Tani, E
    Liedberg, A
    Skoog, L
    Rutqvist, LE
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2002, 71 (02) : 161 - 170
  • [9] Brown RW, 1996, CLIN CANCER RES, V2, P585
  • [10] Meta-analysis confirms BCL2 is an independent prognostic marker in breast cancer
    Callagy, Grace M.
    Webber, Mark J.
    Pharoah, Paul D. P.
    Caldas, Carlos
    [J]. BMC CANCER, 2008, 8 (1)